Market Overview:
The global autoimmune disorder drug delivery devices market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The market growth can be attributed to factors such as the increasing prevalence of autoimmune disorders, technological advancements in drug delivery devices, and rising demand for self-injection devices. Based on type, the global autoimmune disorder drug delivery devices market is segmented into pen injectors, auto-injectors, pre-filled syringes, and vials. The pen injector segment is expected to grow at the highest CAGR during the forecast period owing to its advantages such as ease of use and accuracy. Based on application, the global autoimmune disorder drug delivery devices market is segmented into hospital and clinic settings. The hospital setting segment is expected to grow at a higher rate than the clinic setting segment during the forecast period owing to an increase in awareness about available treatment options for patients with autoimmune disorders.
Product Definition:
Autoimmune Disorder Drug Delivery Devices are devices that help to deliver drugs to patients suffering from autoimmune disorders. By delivering the drugs directly to the affected area, these devices can help to improve the efficacy of the drug therapy and reduce side effects.
Pen Injectors:
Pen injectors are devices used to deliver drugs in the form of a needle. They are mostly preferred by people who have difficulty in swallowing or cannot take pills. Pen injectors can be easily attached to mobile devices that help patients record their prescriptions and receive alerts for upcoming doses.
Pen injectors have been gaining popularity as they enable effective drug delivery, which is not possible with other delivery systems such as syringes and tablets owing to their poor oral bioavailability.
Auto-Injectors:
An auto-injector is a device used to inject drugs. It consists of an injection pen, which contains the drug to be injected and a mechanism that is operated by pressing one or more buttons on the device. Auto-injectors are widely used for delivering insulin in patients suffering from diabetes mellitus.
Application Insights:
The hospital application segment dominated the global market in 2017. The growing prevalence of chronic diseases, such as diabetes and autoimmune disorders, is expected to be a major factor for the growth of this segment over the forecast period. According to a study published by NCBI in 2018, it was found that around 60-80% of patients suffering from rheumatoid arthritis require long-term antirheumatic drug therapy (LTT). Thus, increasing number of hospital admissions for treatment purposes is anticipated to contribute towards revenue generation during the forecast period.
Clinic applications are expected to witness significant growth over the forecast period owing to rising awareness about available treatment options among individuals affected with autoimmune disorders and an increase in clinics offering these treatments. For instance, according to data published by CDC in 2016, around 54 million adults aged 18 years or older were diagnosed with arthritis or another type of joint disorder across America alone.
Regional Analysis:
North America dominated the global market in 2017. The presence of a large number of autoimmune disorders and target population are some factors driving the regional market. In addition, favorable reimbursement policies for auto-injector devices are also expected to drive their adoption over the forecast period.
Asia Pacific is expected to grow at a lucrative rate during the forecast period owing to high unmet medical needs coupled with rapidly improving healthcare infrastructure in emerging countries such as China & India.
Growth Factors:
- Increasing incidence of autoimmune disorders
- Growing demand for minimally invasive therapies
- Technological advancements in drug delivery devices
- Rising awareness about autoimmune disorder treatments
- Growing number of collaborations and partnerships between pharmaceutical companies and medical device manufacturers
Scope Of The Report
Report Attributes
Report Details
Report Title
Autoimmune Disorder Drug Delivery Devices Market Research Report
By Type
Pen Injectors, Auto-Injectors, Pre-filled Syringes, Vials
By Application
Hospital, Clinic
By Companies
BD, Gerresheimer, Schott, J.O.Pharma, Nipro, Roselabs, Fresenius Kabi, Baxter, West Pharma, Terumo, Taisei Kako, MedXL, Cardinal Health, Guerbet, Catalent, Weigao, Stevanato, Rovi CM, Zibo Minkang, Vetter Pharma
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
194
Number of Tables & Figures
136
Customization Available
Yes, the report can be customized as per your need.
Global Autoimmune Disorder Drug Delivery Devices Market Report Segments:
The global Autoimmune Disorder Drug Delivery Devices market is segmented on the basis of:
Types
Pen Injectors, Auto-Injectors, Pre-filled Syringes, Vials
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Clinic
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- BD
- Gerresheimer
- Schott
- J.O.Pharma
- Nipro
- Roselabs
- Fresenius Kabi
- Baxter
- West Pharma
- Terumo
- Taisei Kako
- MedXL
- Cardinal Health
- Guerbet
- Catalent
- Weigao
- Stevanato
- Rovi CM
- Zibo Minkang
- Vetter Pharma
Highlights of The Autoimmune Disorder Drug Delivery Devices Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Pen Injectors
- Auto-Injectors
- Pre-filled Syringes
- Vials
- By Application:
- Hospital
- Clinic
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Autoimmune Disorder Drug Delivery Devices Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Autoimmune disorder drug delivery devices are medical devices that help patients with autoimmune disorders take their medications more easily and effectively. These devices can include pumps, inhalers, and patches that deliver medication directly to the patient's lungs or skin.
Some of the major players in the autoimmune disorder drug delivery devices market are BD, Gerresheimer, Schott, J.O.Pharma, Nipro, Roselabs, Fresenius Kabi, Baxter, West Pharma, Terumo, Taisei Kako, MedXL, Cardinal Health, Guerbet, Catalent, Weigao, Stevanato, Rovi CM, Zibo Minkang, Vetter Pharma.
The autoimmune disorder drug delivery devices market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Autoimmune Disorder Drug Delivery Devices Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Autoimmune Disorder Drug Delivery Devices Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Autoimmune Disorder Drug Delivery Devices Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Autoimmune Disorder Drug Delivery Devices Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Autoimmune Disorder Drug Delivery Devices Market Size & Forecast, 2018-2028
4.5.1 Autoimmune Disorder Drug Delivery Devices Market Size and Y-o-Y Growth
4.5.2 Autoimmune Disorder Drug Delivery Devices Market Absolute $ Opportunity
Chapter 5 Global Autoimmune Disorder Drug Delivery Devices Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Autoimmune Disorder Drug Delivery Devices Market Size Forecast by Type
5.2.1 Pen Injectors
5.2.2 Auto-Injectors
5.2.3 Pre-filled Syringes
5.2.4 Vials
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Autoimmune Disorder Drug Delivery Devices Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Autoimmune Disorder Drug Delivery Devices Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Clinic
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Autoimmune Disorder Drug Delivery Devices Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Autoimmune Disorder Drug Delivery Devices Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Autoimmune Disorder Drug Delivery Devices Analysis and Forecast
9.1 Introduction
9.2 North America Autoimmune Disorder Drug Delivery Devices Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Autoimmune Disorder Drug Delivery Devices Market Size Forecast by Type
9.6.1 Pen Injectors
9.6.2 Auto-Injectors
9.6.3 Pre-filled Syringes
9.6.4 Vials
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Autoimmune Disorder Drug Delivery Devices Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Clinic
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Autoimmune Disorder Drug Delivery Devices Analysis and Forecast
10.1 Introduction
10.2 Europe Autoimmune Disorder Drug Delivery Devices Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Autoimmune Disorder Drug Delivery Devices Market Size Forecast by Type
10.6.1 Pen Injectors
10.6.2 Auto-Injectors
10.6.3 Pre-filled Syringes
10.6.4 Vials
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Autoimmune Disorder Drug Delivery Devices Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Clinic
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Autoimmune Disorder Drug Delivery Devices Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Autoimmune Disorder Drug Delivery Devices Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Autoimmune Disorder Drug Delivery Devices Market Size Forecast by Type
11.6.1 Pen Injectors
11.6.2 Auto-Injectors
11.6.3 Pre-filled Syringes
11.6.4 Vials
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Autoimmune Disorder Drug Delivery Devices Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Clinic
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Autoimmune Disorder Drug Delivery Devices Analysis and Forecast
12.1 Introduction
12.2 Latin America Autoimmune Disorder Drug Delivery Devices Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Autoimmune Disorder Drug Delivery Devices Market Size Forecast by Type
12.6.1 Pen Injectors
12.6.2 Auto-Injectors
12.6.3 Pre-filled Syringes
12.6.4 Vials
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Autoimmune Disorder Drug Delivery Devices Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Clinic
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Autoimmune Disorder Drug Delivery Devices Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Autoimmune Disorder Drug Delivery Devices Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Autoimmune Disorder Drug Delivery Devices Market Size Forecast by Type
13.6.1 Pen Injectors
13.6.2 Auto-Injectors
13.6.3 Pre-filled Syringes
13.6.4 Vials
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Autoimmune Disorder Drug Delivery Devices Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Clinic
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Autoimmune Disorder Drug Delivery Devices Market: Competitive Dashboard
14.2 Global Autoimmune Disorder Drug Delivery Devices Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 BD
14.3.2 Gerresheimer
14.3.3 Schott
14.3.4 J.O.Pharma
14.3.5 Nipro
14.3.6 Roselabs
14.3.7 Fresenius Kabi
14.3.8 Baxter
14.3.9 West Pharma
14.3.10 Terumo
14.3.11 Taisei Kako
14.3.12 MedXL
14.3.13 Cardinal Health
14.3.14 Guerbet
14.3.15 Catalent
14.3.16 Weigao
14.3.17 Stevanato
14.3.18 Rovi CM
14.3.19 Zibo Minkang
14.3.20 Vetter Pharma
